2008
DOI: 10.1016/s0022-5347(08)61418-4
|View full text |Cite
|
Sign up to set email alerts
|

Alfuzosin Stone Expulsion Therapy for Distal Ureteral Calculi: A Double-Blind Placebo- Controlled Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
1
2

Year Published

2009
2009
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 0 publications
0
12
1
2
Order By: Relevance
“…Recently, many agents have been used to facilitate stone passage along the ureter with or without SWL. Among these agents a-blockers have proven effective in facilitating stone passage [3][4][5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…Recently, many agents have been used to facilitate stone passage along the ureter with or without SWL. Among these agents a-blockers have proven effective in facilitating stone passage [3][4][5][6][7][8].…”
Section: Introductionmentioning
confidence: 99%
“…[28] Diğer randomize, plasebo kontrollü çalışmada ise tamsulosin ve plasebonun etkinlikleri karşılaştırılmıştır. Bunun istisnası olan üç çalışma vardır.…”
Section: Tablo 1 Kalsiyum Kanal Blokörü Ve Alfa Blokörlerin Medikal unclassified
“…Nifedipine (40 mg/d [7] or 30 mg/d extended release [8][9][10][11][12] ) Alfuzosin (dosage not reported) [13] Doxazosin (4 mg) [14,15] Tamsulosin (0.4 mg/d) [14,[16][17][18][19] Terazosin (5 mg/d) [14,19] Clinical trial design and details Randomized [7][8][9]11,12] or nonrandomized [10] No. of pts per treatment group: 25-70 Mean stone size: 3.9-12.8 mm; stone location generally distal Nifedipine recipients also received concomitant methylprednisolone, [7] ketorolac, [8] deflazacort [9,11,12] or prednisolone [10] Control groups received the same adjunctive drug with [7] or without placebo [8,10,12] (one study control was prednisolone and ketorolac, [8] another was phloroglucinol and deflazacort [12] ); in other studies they were just labelled as controls [9,11] Randomized [13][14][15][16][17][18][19] No.…”
Section: Drugs In Class That Has Been Investigated In This Indicationmentioning
confidence: 99%
“…of pts per treatment group: 25-70 Mean stone size: 3.9-12.8 mm; stone location generally distal Nifedipine recipients also received concomitant methylprednisolone, [7] ketorolac, [8] deflazacort [9,11,12] or prednisolone [10] Control groups received the same adjunctive drug with [7] or without placebo [8,10,12] (one study control was prednisolone and ketorolac, [8] another was phloroglucinol and deflazacort [12] ); in other studies they were just labelled as controls [9,11] Randomized [13][14][15][16][17][18][19] No. of pts per treatment group: 15-50 Mean stone size: 3.0-7.8 mm Pts received a-blockers with [14][15][16][17][18][19] or without [13] standard treatment (diclofenac, [15,16] tenoxicam, [14,17] diclofenac plus horse chestnut extract, [18] or ketorolac plus buprenorphine [19] ) Control groups received standard treatment [14][15][16][17][18][19] or placebo [13] Clinical trial results (investigative drug vs control)…”
Section: Drugs In Class That Has Been Investigated In This Indicationmentioning
confidence: 99%
See 1 more Smart Citation